All Medicus, The Republic of Korea - Komachine Supplier Profile and Product List

- All Medicus Co., Ltd. is a specialized blood diagnostic company established in 1997, known for developing and mass-producing Korea's first self-monitoring blood glucose meter, 'GlucoDr'. The company manufactures medical devices, biosensors, airway resistance measurement devices, and E-healthcare products, providing solutions for measuring various health indicators in blood. Its core technology involves electrochemical biosensors based on high-purity gold electrodes, with ongoing expansion into E-healthcare and molecular diagnostics through IT-BT convergence technologies.All Medicus Co., Ltd. is a specialized blood diagnostic company established in 1997, known for developing and mass-producing Korea's first self-monitoring blood glucose meter, 'GlucoDr'. The company manufactures medical devices, biosensors, airway resistance measurement devices, and E-healthcare products, providing solutions for measuring various health indicators in blood. Its core technology involves electrochemical biosensors based on high-purity gold electrodes, with ongoing expansion into E-healthcare and molecular diagnostics through IT-BT convergence technologies.
- GlucoDr.S (Model AGM-513S): Requires 0.5µl blood sample, 5-second test time, 20-600mg/dL test range, 20-65% hematocrit range, no-coding system, 500 test memory, and Micro USB data transmission.GlucoDr.S (Model AGM-513S): Requires 0.5µl blood sample, 5-second test time, 20-600mg/dL test range, 20-65% hematocrit range, no-coding system, 500 test memory, and Micro USB data transmission.
- GlucoDr. auto (Model AGM-4000): Requires 0.5µl blood sample, 5-second test time, 10-900mg/dL test range, auto-coding system, 500 test memory, and PC connectivity.GlucoDr. auto (Model AGM-4000): Requires 0.5µl blood sample, 5-second test time, 10-900mg/dL test range, auto-coding system, 500 test memory, and PC connectivity.
- GlucoDr. Plus (Model AGM-3000): Requires 2µl blood sample (minimum 1.5µl), 5-second test time, 20-900mg/dL test range, compatible with GlucoDr SuperSensor or GlucoDr Plus strips, with an AGM-3000B model supporting Bluetooth communication.GlucoDr. Plus (Model AGM-3000): Requires 2µl blood sample (minimum 1.5µl), 5-second test time, 20-900mg/dL test range, compatible with GlucoDr SuperSensor or GlucoDr Plus strips, with an AGM-3000B model supporting Bluetooth communication.
- GlucoDr. Slim (Model AGM-2300): Part of the self-monitoring blood glucose meter series.GlucoDr. Slim (Model AGM-2300): Part of the self-monitoring blood glucose meter series.
- GlucoDr SuperSensor (Model AGM-2200): Requires 2µl blood sample (minimum 1.5µl), 10-second test time, 20-900mg/dL test range, 250 test memory, RS-232C data transmission, and utilizes advanced electrochemical biosensor technology.GlucoDr SuperSensor (Model AGM-2200): Requires 2µl blood sample (minimum 1.5µl), 10-second test time, 20-900mg/dL test range, 250 test memory, RS-232C data transmission, and utilizes advanced electrochemical biosensor technology.
- GlucoDr™ (Model AGM-2100): Requires 4µl blood sample (0.4µl according to Danawa), 11-second test time, 20-600mg/dL test range (30-600mg/dL according to Danawa), button calibration method, and 100 test memory.GlucoDr™ (Model AGM-2100): Requires 4µl blood sample (0.4µl according to Danawa), 11-second test time, 20-600mg/dL test range (30-600mg/dL according to Danawa), button calibration method, and 100 test memory.
- LinkDr™2.0 Software: A software solution for managing and analyzing blood glucose measurement data.LinkDr™2.0 Software: A software solution for managing and analyzing blood glucose measurement data.
- E-Health: Development and promotion of E-healthcare products and mobile healthcare platforms, central to the IT-BT convergence market.E-Health: Development and promotion of E-healthcare products and mobile healthcare platforms, central to the IT-BT convergence market.
- OCP-3000: An airway resistance measurement device.OCP-3000: An airway resistance measurement device.
- Pioneering Domestic Blood Glucose Meter Development: Successfully introduced Korea's first 'Made in Korea' blood glucose meter, 'Choice Plus,' in 1999, demonstrating early technological leadership.Pioneering Domestic Blood Glucose Meter Development: Successfully introduced Korea's first 'Made in Korea' blood glucose meter, 'Choice Plus,' in 1999, demonstrating early technological leadership.
- High-Purity Gold Electrode-Based Electrochemical Biosensor Technology: A core technological capability providing high accuracy and reliability, reducing measurement errors and enabling a wide measurement range (20-900mg/dL).High-Purity Gold Electrode-Based Electrochemical Biosensor Technology: A core technological capability providing high accuracy and reliability, reducing measurement errors and enabling a wide measurement range (20-900mg/dL).
- Quality Validation through Domestic and International Hospital Supply: A history of supplying products to demanding domestic and international hospitals since its early stages, earning recognition for its technology and quality.Quality Validation through Domestic and International Hospital Supply: A history of supplying products to demanding domestic and international hospitals since its early stages, earning recognition for its technology and quality.
- Continuous R&D and Investment in IT-BT Convergence Technology: A commitment to innovation, focusing on nurturing future core businesses by expanding into E-healthcare and molecular diagnostics.Continuous R&D and Investment in IT-BT Convergence Technology: A commitment to innovation, focusing on nurturing future core businesses by expanding into E-healthcare and molecular diagnostics.
- Global Market Entry and International Certifications: Exporting products to over 60 countries worldwide and holding numerous international quality certifications including FDA, CE, ISO 13485, GMP, and China NMPA.Global Market Entry and International Certifications: Exporting products to over 60 countries worldwide and holding numerous international quality certifications including FDA, CE, ISO 13485, GMP, and China NMPA.
- Extensive Patent Portfolio: Securing proprietary technologies through patents such as electrochemical biosensors (gold electrode), auto-coding, hematocrit correction, blood absorption recognition electrodes, and plasma-blood cell separation.Extensive Patent Portfolio: Securing proprietary technologies through patents such as electrochemical biosensors (gold electrode), auto-coding, hematocrit correction, blood absorption recognition electrodes, and plasma-blood cell separation.
- Medical and Healthcare Industry: Self-management of blood glucose for diabetic patients and in-hospital blood diagnostic applications.Medical and Healthcare Industry: Self-management of blood glucose for diabetic patients and in-hospital blood diagnostic applications.
- E-Healthcare and Mobile Healthcare Industry: Providing customized health management solutions utilizing IT-BT convergence technologies.E-Healthcare and Mobile Healthcare Industry: Providing customized health management solutions utilizing IT-BT convergence technologies.
- Molecular Diagnostics Industry: Pursuing the development of POCT-type molecular diagnostic platforms using nucleic acid isothermal amplification technology.Molecular Diagnostics Industry: Pursuing the development of POCT-type molecular diagnostic platforms using nucleic acid isothermal amplification technology.
- Indonesia, China, Malaysia (planned expansion in Southeast Asian markets)Indonesia, China, Malaysia (planned expansion in Southeast Asian markets)
- GermanyGermany
- BrazilBrazil
- FDA 510K Letter (AGM-513S, GlucoDr.S; AGM-4000, GlucoDr.auto).FDA 510K Letter (AGM-513S, GlucoDr.S; AGM-4000, GlucoDr.auto).
- CE Certificate.CE Certificate.
- ISO 13485 Certificate.ISO 13485 Certificate.
- Certificate of GMP.Certificate of GMP.
- China NMPA Certificate (AGM-4000, GlucoDr.auto_Strip; AGM-4000, GlucoDr.auto_Meter).China NMPA Certificate (AGM-4000, GlucoDr.auto_Strip; AGM-4000, GlucoDr.auto_Meter).
- Acquisition of 'Excellent Korea Technology - KT Mark' from the Ministry of Science and Technology and 'New Technology - NT Mark' from the Ministry of Commerce, Industry and Energy (for portable blood glucose monitoring system).Acquisition of 'Excellent Korea Technology - KT Mark' from the Ministry of Science and Technology and 'New Technology - NT Mark' from the Ministry of Commerce, Industry and Energy (for portable blood glucose monitoring system).
- IR52 Jang Young-shil Award (2005, for disposable blood glucose biosensor system 'GlucoDr SuperSensor').IR52 Jang Young-shil Award (2005, for disposable blood glucose biosensor system 'GlucoDr SuperSensor').
- Electrochemical biosensor patent (gold electrode).Electrochemical biosensor patent (gold electrode).
- Auto-coding patent.Auto-coding patent.
- Hematocrit correction patent.Hematocrit correction patent.
- Blood absorption recognition electrode patent.Blood absorption recognition electrode patent.
- Plasma-blood cell separation patent.Plasma-blood cell separation patent.
- 9 domestic and international patent applications (as of 2001).9 domestic and international patent applications (as of 2001).
- Possession of 42 patents in total (as of November 2025).Possession of 42 patents in total (as of November 2025).